Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
Drug-resistant tuberculosis (TB) is one of the most lethal diseases, and it is imperative to exploit an advanced drug formulation for its effective treatment. This work aims to develop a mannose receptor-targeted bioadhesive chitosan nanoparticles for effective drug-resistant tuberculosis treatment....
Saved in:
Main Authors: | Datta Maroti Pawde (Author), Matte Kasi Viswanadh (Author), Abhishesh Kumar Mehata (Author), Roshan Sonkar (Author), Narendra (Author), Suruchi Poddar (Author), Ankita Sanjay Burande (Author), Abhishek Jha (Author), Kiran Yellappa Vajanthri (Author), Sanjeev Kumar Mahto (Author), V.N. Azger Dustakeer (Author), Madaswamy S. Muthu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023) -
Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
by: Abhishesh Kumar Mehata, et al.
Published: (2023) -
Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
by: Natasha Manners, et al.
Published: (2022) -
Clofazimine: A Promising Inhibitor of Rabies Virus
by: Jiajing Wu, et al.
Published: (2021) -
Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
by: Ronald Anderson, et al.
Published: (2018)